Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 870.02M | $ 1.02B | $ 522.65M | $ 438.94M | $ 75.10M |
Total Assets | $ 2.18B | $ 1.86B | $ 1.12B | $ 929.25M | $ 271.53M |
Total Debt | $ 949.03M | $ 873.23M | $ 484.75M | $ 421.93M | $ ― |
Net Debt | $ 79.00M | $ -146.38M | $ -37.89M | $ -17.01M | $ ― |
Total Liabilities | $ 1.22B | $ 1.17B | $ 713.00M | $ 590.89M | $ 61.95M |
Stockholders Equity | $ 960.98M | $ 684.79M | $ 411.78M | $ 338.35M | $ 209.59M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |